Naturally Processed HLA Class II Peptides Reveal Highly Conserved Immunogenic Flanking Region Sequence Preferences That Reflect Antigen Processing Rather Than Peptide-MHC Interactions-Reference-Cited by-同舟云学术

Naturally Processed HLA Class II Peptides Reveal Highly Conserved Immunogenic Flanking Region Sequence Preferences That Reflect Antigen Processing Rather Than Peptide-MHC Interactions

Published:2001-06-01 Issue:11 Volume:166 Page:6720-6727
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Godkin Andrew J.,Smith Kathrine J.,Willis Anthony,Tejada-Simon Maria V.,Zhang Jingwu,Elliott Tim,Hill Adrian V. S.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference35 articles.

1. Chemistry of peptides associated with MHC class I and class II molecules

2. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide

3. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3

4. X-Ray Crystal Structure of HLA-DR4 (DRA*0101, DRB1*0401) Complexed with a Peptide from Human Collagen II

5. Crystal Structure of HLA-DR2 (DRA*0101, DRB1*1501) Complexed with a Peptide from Human Myelin Basic Protein

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating Cross-linking-driven integrative modeling in peptide-HLAII complexes prediction with insights for refining predictive accuracy;2024-09-03

2. A targeted single mutation in influenza A virus universal epitope transforms immunogenicity and protective immunity via CD4+ T cell activation;Cell Reports;2024-06

3. MHCII-peptide presentation: an assessment of the state-of-the-art prediction methods;Frontiers in Immunology;2024-03-12

4. Structure-aware deep model for MHC-II peptide binding affinity prediction;BMC Genomics;2024-01-30

5. Preclinical risk assessment strategy to mitigate the T-cell dependent immunogenicity of protein biotherapeutics: State of the art, challenges and future perspectives;Journal of Pharmaceutical and Biomedical Analysis;2023-09